CRESCENT BIOPHARMA, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| HENOS MICHAEL A | — | X | 43,628 | $0.33 | $14,397 | 497,436 | Dec 17, 2014 |
| King Rachel K. | President, CEO | Option Exercise | 100,000 | $1.12 | $112,000 | 108,706 | Jun 18, 2014 |
| HENOS MICHAEL A | — | Purchase | 6,000 | $6.54 | $39,240 | 7,562 | Jun 13, 2014 |
| HENOS MICHAEL A | — | Option Exercise | 1,562 | $1.12 | $1,749 | 1,562 | Apr 3, 2014 |
| BARRIS PETER J | — | C | 3,580,877 | — | — | 3,580,877 | Jan 15, 2014 |
| SANDELL SCOTT D | — | Purchase | 512,500 | $8.00 | $4,100,000 | 4,093,377 | Jan 15, 2014 |
| BARRETT M JAMES | — | Purchase | 512,500 | $8.00 | $4,100,000 | 4,093,377 | Jan 15, 2014 |
| NEW ENTERPRISE ASSOCIATES 13 LP | — | C | 3,580,877 | — | — | 3,580,877 | Jan 15, 2014 |
| NEA PARTNERS 10 L P | — | Purchase | 487,500 | $8.00 | $3,900,000 | 4,481,758 | Jan 15, 2014 |
| Magnani John L. | VP of Research, CSO | C | 9,969 | — | — | 90,374 | Jan 15, 2014 |
| HENOS MICHAEL A | — | C | 11,936 | — | — | 22,668 | Jan 15, 2014 |
| Gust William M. | — | C | 339,686 | — | — | 409,947 | Jan 15, 2014 |